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ABSTRACT. Objective: Among Finnish adolescent twins, we compared 
(a) a model that describes a direct impact of liability to tobacco use 
on cannabis and other illicit drug use with (b) a model that included a 
shared underlying liability for these substances. Furthermore, the extent 
to which genetic and environmental infl uences contribute to the covaria-
tion between liabilities to use these substances was examined. Method: 
Tobacco and illicit drug use were assessed at age 17.5 years. Twin data 
on 3,744 individuals were analyzed using standard biometrical methods. 
Two alternative multivariate models were fi t and compared with Mx, a 
statistical program for genetic model fi tting. Results: The multivariate 
model, including a direct impact of the initiation of tobacco use on illicit 
drug use, provided the best fi t to the data. In this model, the total varia-
tion in the initiation of illicit drugs was decomposed to genetic factors 
(32%), common environmental factors (20%), unique environmental 
factors (8%), and a component due to initiation of smoking (40%). Most 
variation in the progression of illicit drug use was the result of initiation 
of smoking and illicit drug use (83%). Conclusions: Liability to initiate 
smoking directly affects illicit drug use in our best-fi tting model. Our 
fi ndings suggest that several common genetic infl uences may be related 
to tobacco use and illicit drugs but that a search for specifi c genes 
underlying illicit drug use is justifi ed as well. Such specifi c genes may 
hold a key to understanding biological vulnerabilities that lead to illicit 
drug use, which could aid in the development of targeted interventions. 
(J. Stud. Alcohol Drugs, 71, 5-14, 2010)
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SMOKING CIGARETTES IS COMMON among adoles-cents, of whom approximately 60% have ever smoked a 
cigarette and about 33% have smoked during the last month, 
according to recent surveys throughout Europe (Hibell et al., 
2009). Although less prevalent than smoking, cannabis is 
the most commonly used and abused illicit drug in Western 
countries. Early onset of cannabis use has been shown to be 
a consistent, strong predictor of substance-related problems 
(Hawkins et al., 1992; Lynskey et al., 2003) and may result 
in adverse psychiatric effects, such as depression and psy-
chotic illness. Adolescent users are especially vulnerable to 
these effects (Ferdinand et al., 2005; Fergusson et al., 2002; 
Rey et al., 2004). Therefore, more insight into the risk factors 
and mechanisms that may lead to initiation and continuation 
of cannabis use is needed for the development of effective 
prevention and treatment programs.
 In adolescence, tobacco is often the fi rst drug used (Li, 
2003), followed by other drugs, such as cannabis. Because 
this sequence in substance use is found frequently, several 
studies have focused on tobacco use as a fi rst “gateway” for 
cannabis use (e.g., Kandel et al., 2006). Similarly, cannabis 
use has been regarded as a second gateway to the subsequent 
use of other illicit drugs (Fergusson and Horwood, 2000; Fer-
gusson et al., 2006). These gateway theories for tobacco, and 
particularly for cannabis use, have been a source of recent 
and lively debate (e.g., Anthony, 2002; Kandel et al., 2006; 
Kenkel and Mathios, 2002; Lynskey, 2002; Maccoun, 2006). 
Although most researchers emphasize the co-occurrence of 
use of various substances and agree with the normative se-
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quence (Degenhardt et al., 2009)—beginning with licit drugs, 
such as alcohol and tobacco, followed by cannabis, then other 
illicit drugs—they differ in respect to how these phenomena 
can be explained. As a plausible alternative to the gateway 
theory, a common factor model, has been postulated (Mor-
ral et al., 2002), which may, for instance be refl ected in an 
individual’s propensity to associate with others who use drugs 
(Lynksey et al., 1998), or by a common genetic vulnerability 
underlying any substance use (Lynskey, 2002).
 Recently, evidence has been found for a reverse gateway 
(i.e., cannabis use precedes cigarette smoking) that contra-
dicts the gateway theory (Clough, 2005; Patton et al., 2005; 
Viveros et al., 2006). This would suggest that a common 
liability or common factor model, representing a common 
underlying factor, may explain the often observed co-occur-
rence of tobacco use and cannabis use, irrespective of the 
sequence of use of these substances.
 In a previous study within our Finnish twin cohort, 
predictors for use of cannabis and other illicit drugs were 
investigated. In the fi nal regression model, smoking initia-
tion by age 12 years was the most powerful predictor among 
the individual-based analysis, with an odds ratio of 26 (p 
< .001). A similar association could be replicated within 
a matched case-control design, including discordant twin 
pairs only (odds ratio = 22, p < .001; Korhonen et al., 2008), 
in which one twin of a pair used drugs and the other twin 
did not. These fi ndings provide evidence for a particularly 
strong temporal association between the onset of smoking 
at an early age and the subsequent onset of cannabis use. In 
the current study, we extend these fi ndings by focusing on 
the underlying shared or specifi c genetic and environmental 
contributions to these outcomes.
 Recently, Neale et al. (2006) described novel extensions to 
the modeling of the latent liability to initiate and progress the 
use of substances, including the development of fi rst using 
one substance and then progressing to use of another sub-
stance. In their study, the authors described on a statistical 
level why previously existing models explaining the relation 
between initiation and progression of the use of one particu-
lar substance (or, univariate models) were diffi cult to extend 
to, for instance, multivariate models that included initiation 
and progression of the use of two different substances. They 
overcame this problem with their novel approach, which re-
garded the analysis of twin data on initiation and progression 
as a special case of missing data, as previously performed by 
Heath et al. (2002), wherein individuals who do not initiate 
are regarded as having missing data on progression mea-
sures. In addition, Neale et al. (2006) extended these models 
by jointly testing a series of causal, common, and contingent 
models. They illustrated this novel approach with several 
models, including one that is of particular relevance for our 
current study. In this multivariate model, reciprocal relations 
between both tobacco use and cannabis use initiation and 
progression were modeled. Therefore, it tests whether the li-
ability to use one substance is a risk factor for use of another 
substance, or vice versa, in a sample of female adult twins. 
Their results showed a slightly better fi t for the causal model, 
compared with a common liability model.
 In the present study, we built on this novel approach to 
model genetically informative data, and analyzed the pat-
tern of liability to initiate tobacco and cannabis use and the 
progress of use in an adolescent twin sample. Examining the 
genetic vulnerability to progress from initiation of cigarette 
smoking to cannabis use will provide insight into the poten-
tial mechanisms underlying this phenomenon. Within our 
large-scale adolescent twin study of boys and girls, we evalu-
ated (a) whether a model in which the liability to initiate to-
bacco use directly affects the liability to initiate cannabis use 
or a model in which use of these substances are correlated 
because of shared liabilities, represented by shared genetic 
and environmental infl uences, better fi ts observed data; and 
(b) the extent to which genetic and environmental infl uences 
contribute to the covariation between the initiation and pro-
gression of tobacco and cannabis and other illicit drug use.
Method
Participants
 The FinnTwin12 study—a collaborative research project 
of the Universities of Helsinki and Jyväskylä in Finland 
and Indiana University in the United States—was started in 
1994 to examine genetic and environmental determinants of 
precursors of health-related behaviors in twins initially age 
10 to 12 years (born in 1983-1987). The epidemiological 
investigation of fi ve consecutive and complete birth cohorts 
of Finnish twin children (n = 5,600 twins and 5,000 parents 
from 2,800 families) included questionnaire assessments 
provided by twins, their parents, teachers, and classmates. 
The study protocol was approved by the institutional review 
board of Indiana University and the Ethical Committee of 
the University of Helsinki. The baseline was conducted late 
in the year before the twins reached age 12 years, with fol-
low-ups at ages 14 and 17.5 years (Kaprio, 2006).
 For this study, we used data collected from the third 
wave of the study, which was initiated in autumn of 2000 
and completed in spring of 2005 (response rate: 92%; 4,236 
questionnaires were returned from 4,594 mailed). Question-
naires were mailed out semi-annually to each half of a birth 
cohort, with the average age at mailing of 17.5 years. Among 
the 4,236 participants, 107 had missing data on essential 
study variables. Furthermore, we excluded those individuals 
who did not have data from their co-twin (n = 161). We also 
excluded participants whose zygosity could not be confi rmed 
(n = 224). Thus, the twin sample of the current investigation 
included 3,744 individuals (1,872 twin pairs: 632 monozy-
gotic [MZ], 287 males, and 345 females; 1,240 dizygotic 
[DZ], 322 males, 315 females, and 603 opposite sex).
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Substance-use measures
 We applied four main substance-use measures to describe 
variables that were modeled as latent liabilities: initiation and 
progression of cigarette smoking, and initiation and progres-
sion of cannabis use.
 Smoking initiation. Smoking initiation was assessed with 
the following question: “Have you ever smoked cigarettes (or 
experimented with at least one cigarette)?” (yes/no).
 Smoking progression. Those who had ever smoked were 
classifi ed into (a) nondaily smoking (had smoked fewer than 
51 cigarettes in their lifetime or smoked 51 or more ciga-
rettes but who were not daily smokers) and (b) daily smok-
ing (had smoked at least 51 cigarettes and who were daily 
smokers). Participants who never initiated cigarette smoking 
had missing data for progression. We used this limit of life-
time exposure because, in a national survey among Finnish 
adolescents, only those who had lifetime use of more than 
50 cigarettes were considered as progressed beyond smoking 
experimentation (Rimpelä et al., 2007).
 Initiation of cannabis and other illicit drug use. Initia-
tion was assessed by asking, “Have you ever tried or used 
drugs, such as hashish, something to sniff, or other drugs 
or substances that would make you feel intoxicated?” The 
options were the following: (a) I have never tried or used, 
(b) 1-3 times, (c) 4-9 times, (d) 10-19 times, and (e) 20 
times or more. Our own unpublished interview data among 
a subsample of 1,852 intensively assessed twins at age 14 
years shows that some 90% of reported illicit drug use was 
specifi cally cannabis use and less than 1% had ever used any 
substance other than tobacco, alcohol, or marijuana, which 
was in line with recent Finnish statistics (Virtanen and Sjö-
berg, 2006). However, because of the wording of our ques-
tion, we chose to refer to “cannabis/other illicit drug use” or 
just “illicit drug use” throughout this article. To defi ne the 
initiation of cannabis/other illicit drug use, we considered 
all who reported experimenting or using at least once in a 
lifetime as “initiated.”
 Progression of cannabis/other illicit drug use. Progression 
was defi ned as using four to nine times or more. A similar 
limit, such as marijuana use six or more times (Shelton et 
al., 2007), has been earlier used for progression of cannabis 
use among adolescents, indicating that these individuals have 
proceeded beyond the experimentation stage.
Statistical analyses
 Twin data were analyzed using standard biometrical meth-
ods (Neale and Maes, 2006). We applied basic twin model-
ing, estimating genetic and environmental infl uences on 
our substance-use measures that are modeled as underlying 
normally distributed latent traits (i.e., liabilities to initiate or 
progress in substance use). More specifi cally, the basic twin 
model partitions variance in a trait into: genetic infl uences 
(A); common environmental infl uences shared by a twin pair 
(C); and unique environmental infl uences, also including 
measurement error (E). Such twin modeling is based on the 
knowledge that MZ twins are genetically identical, whereas 
DZ twins share on average 50% of their segregating genes. 
Thus, a greater similarity for MZ twins, compared with DZ 
twins, gives support to the hypothesis that genetic transmis-
sion is a component of importance, under the assumption 
that MZ and DZ share to the same extent their trait-relevant 
environmental experiences. The inclusion of multiple phe-
notypes (i.e., substance-use measures) in the multivariate 
model allows us to study whether overlap between various 
traits (liability to behaviors) is the result of shared genetic or 
environmental infl uences (Boomsma et al., 2002).
 Descriptive analyses were conducted before model fi tting. 
The MZ and DZ prevalences of smoking and illicit drug use 
initiation and progression were examined within males and 
females. Because of a low number of observations in illicit 
drug use progression, we pooled both sexes together into fur-
ther analyses. However, we used different thresholds for men 
and women (refl ecting different prevalence) for the traits in 
the model where needed. In further modeling, sex and age 
were included as covariates.
 Next, conditional causal models were conducted sepa-
rately for initiation and progression of smoking, as well as 
for initiation and progression of illicit drug use. Figure 1 
illustrates the conditional causal model for initiation and 
progression of use of one substance only. It specifi es a direct 
path from initiation to progression within each member of 
a twin pair. For example, A, C, and E infl uences on smok-
ing initiation can also affect smoking progression. This is 
refl ected in the path coeffi cient b in Figure 1. New A, C, 
or E infl uences could also affect progression of use. These 
specifi c infl uences on progression are refl ected by path coef-
fi cients a2, c2, and e2. Two alternate multivariate Mx models 
were tested to explain the associations of stages in smoking 
and cannabis/other illicit drug use. We fi rst tested the causal 
model, which hypothesizes that smoking cigarettes directly 
affects use of illicit drugs, such as cannabis. This model 
allows for the genetic and environmental infl uences on the 
initiation of smoking to infl uence the initiation of cannabis/
other illicit drug use. It requires that all the infl uences are 
passed to the initiation of cannabis/other illicit drug use in 
a proportional way, according to the magnitude of the direct 
path between initiation of smoking and illicit drugs.
 We used the Mx script provided by Neale et al. (2006), 
which we modifi ed for an adolescent population. We as-
sumed that, in this age group in Finland, initiation of illicit 
drug use before initiation of tobacco use is very rare. This 
assumption was supported by our observation within the 
same study (i.e., a subsample of 1,852 twins interviewed 
at age 14 years). By that age, 1.1% had ever used canna-
bis/other illicit drugs. Practically all of the participants were 
cigarette smokers. From these interview data, we concluded 
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FIGURE 1.    Conditional causal model for initiation and progression of each substance use separately. A = additive genetic inﬂ uences; C = common/shared en-
vironmental inﬂ uences; E = unique/unshared environmental inﬂ uences. a1 = path coefﬁ cient related to additive genetic inﬂ uence on initiation of substance use; 
c1 = path coefﬁ cient related to common environmental inﬂ uence on initiation of substance use; e1 = path coefﬁ cient related to shared environmental inﬂ uence 
on initiation of substance use; a2 = path coefﬁ cient related to new additive genetic inﬂ uence on progression of substance use; c2 = path coefﬁ cient related to 
new common environmental inﬂ uence on progression of substance use; e2 = path coefﬁ cient related to new shared environmental inﬂ uence on progression of 
substance use; b = path coefﬁ cient representing A, C, and E inﬂ uences on the initiation of substance use that directly affect progression of substance use.
that the path from cannabis/other illicit drug use initiation 
to smoking initiation could be removed. We then tested the 
Cholesky decomposition as the second model to observe 
whether covariation between liabilities for behaviors—such 
as smoking initiation, onset of cannabis/other illicit drug 
use, as well as progression of smoking and progression of 
cannabis/other illicit drug use—could be accounted for by 
shared genetic or environmental correlations. Genetic or 
environmental correlation between two traits represents the 
extent to which the same genetic or environmental factors 
contribute to the observed correlation between those two 
traits (Neale and Maes, 2006). In general, the Cholesky de-
composition is useful for estimating parameters that can be 
used to partition covariance between the traits into genetic 
and environmental components (Neale et al., 2006). In this 
correlated liability model, we allow for shared inﬂ uences, 
but they may differentially affect initiation of smoking and 
initiation of cannabis/other illicit drug use. Model ﬁ tting is 
used to ﬁ nd the combination of components that best match-
es the observed pattern of familial resemblance in the data. 
Both models were modiﬁ ed additionally by adding covariate 
adjustments, including regression of sex, and quadratic and 
cubic effects of age on substance-use measures. These latter 
effects were added, because of the variation in age at the out-
come assessment at age 17.5 years and because a graphical 
presentation of the data showed a nonlinear trend. Finally, 
to choose the most parsimonious model, the nested sub-
models may be compared with more saturated ones through 
chi-square difference tests, wherein a p value less than .05 
means that the submodel is signiﬁ cantly worse than the less 
parsimonious model including more paths. When comparing 
models that are not nested submodels, such as models with 
the same number of parameters, the Akaike’s Information 
Criteria (AIC) was used. Here, the lower AIC value—often 
a greater negative value—indicates the more parsimonious 
model (Neale and Maes, 2006).
Results
Descriptive statistics
 The mean age among boys was 17.6 years (SD = 0.2, 
range: 17.2-19.3) and among girls was 17.6 years (SD = 
0.3, range: 17.2-19.5). Within our sample, 67.7% of the MZ 
and 72.3% of the DZ twins had initiated smoking, whereas 
12.9% of the MZ twins and 13.6% of the DZ twins had initi-
ated cannabis use by the follow-up age of 17 years. Of those 
who had started smoking, 32.2% of the MZ twins and 37.4% 
of the DZ twins had progressed to daily smoking. Of those 
who had started using cannabis/other illicit drugs, 29.4% of 
the MZ twins and 37.7% of the DZ twins had progressed to 
using four times or more. Table 1 summarizes the number of 
subjects and the prevalence of each substance use for female 
and male MZ twins and DZ twins, as well as for opposite-
sex twins. Some of the prevalences were ordered MZ < DZ, 
suggesting possible competitive sibling interaction effects, 
wherein MZ twins would be less likely to initiate smoking 
or illicit drug use—and once initiated, less likely to progress 
to regular use—than are DZ twins. Thus, we conducted a 
formal test of sibling interaction for each substance-use 
measure. However, no signiﬁ cant siblings interactions were 
found on smoking initiation (p = 1) or progression (p = 1) 
nor illicit drug use initiation (p = .33) or progression (p = 
.27). The number of discordant pairs was very small (<10) 
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in progression of cannabis/other illicit drug use, particularly 
when broken by sex (not shown in tables).
Two-stage models of smoking and illicit drug use
 For smoking, the most parsimonious model (i.e., the one 
with the lowest AIC value), describing liability to initiate and 
progress smoking, was the “ACE” model (-2 log likelihood 
= 7,106.887, 6,366 df, AIC = -5,625.113), including genetic 
(A), common environmental (C), and unique environmental 
(E) infl uences. For illicit drugs, the most parsimonious two-
stage model included an ACE model for initiation and an E 
model, including unique environmental infl uences only, for 
progression (-2 log likelihood = 3,280.099, 4,232 df, AIC = 
-5,183.901). This two-stage model had a better fi t than the 
full model (-2 log likelihood = 3,280.141, 4,234 df, AIC = 
-5,187.859).
Shared and specifi c genetic and environmental infl uences 
on smoking and cannabis
 We tested two different multivariate models, the causal 
model and the Cholesky decomposition, as described in the 
Statistical analyses section. Results of the most parsimoni-
ous causal and Cholesky decomposition models are given 
in Table 2. Figure 2 graphically presents the results of the 
causal model, whereas Figure 3 shows the results of the 
Cholesky decomposition. In these fi gures, the path coeffi -
cients are presented. To derive the A, C, and E components 
in Table 2, representing how much of the variance is ex-
plained by each factor, these path coeffi cients are squared. 
When comparing these models, the causal model provided 
a better fi t (-2 log likelihood = 9,963.550, 10,601 df, AIC 
= -11,238.450), compared with the Cholesky model (-2 
log likelihood = 9,978.852, 10,599 df, AIC = -11,219.148), 
based on the greater negative AIC value (Neale, 2006).
Multivariate causal model
 Based on the results of the most parsimonious multi-
variate causal model (Figure 2), liability to initiate smoking 
indirectly affects liability to progress cannabis/other illicit 
drugs through initiation of the latter (indirect path coeffi cient 
.63 × .97 = .61), but no direct pathway (p = .27) was found 
from smoking initiation to progression of illicit drugs. From 
this latent construct refl ecting liability to initiate smoking 
to progression of smoking, there is a direct pathway (path 
coeffi cient = .42) and also a pathway through initiation of 
cannabis/other illicit drug use (indirect path coeffi cient .63 
× .32 = .20). There are also three more direct pathways sug-
gested by the most parsimonious model: a pathway from 
initiation of cannabis/other illicit drug to progression (path 
coeffi cient = .97), a pathway from initiation of smoking to 
initiation of that illicit drug use (path coeffi cient = .63), and 
a pathway from initiation of illicit drug use to progression 
of smoking (path coeffi cient = .32).
 Standardized estimates of the most parsimonious causal 
model are given in Table 2. The model decomposes the total 
variation in initiation of smoking into additive genetic factors 
(58%), common environmental factors (34%), and unique 
environmental factors (8%). The total variation in progres-
sion of smoking is decomposed to effects of additive genetic 
factors (43%), unique environmental factors (10%), infl u-
ences shared with smoking initiation (41%), and infl uences 
on cannabis initiation (6%). The total variation in initiation 
of cannabis/other illicit drug use is decomposed into four 
components: (a) additive genetic factors (32%), (b) common 
environmental factors (20%), (c) unique environmental fac-
tors (8%), and (d) component due to initiation of smoking 
(40%). The total variation in cannabis/other illicit drug use 
progression is decomposed to unique environmental factors 
(17%) and paths due to initiation of cannabis/other illicit 
drug use and indirect effect of smoking initiation (83%).
TABLE 1.    The number of subjects and prevalence of each substance use measure for female 
and male monozygotic (MZ), dizygotic (DZ), and opposite-sex twins
 No. of subjects Prevalence (%)
Substance use measure MZ DZ OS MZ DZ OS
Smoking initiation
 Male 574 644 603 67.9 69.1 71.0
 Female 690 630 603 67.5 73.0 76.1
Smoking progression
 Male 386a 442a 428a 33.9a 37.1a 39.5a
 Female 463a 458a 459a 30.7a 35.2a 37.9a
Initiation of illicit drug use
 Male 574 644 603 11.7 11.3 12.9
 Female 690 630 603 13.9 12.7 17.7
Progression of illicit drug use
 Male 67a 73a 78a 19.4a 37.0a 44.9a
 Female 96a 80a 107a 36.5a 32.5a 36.4a
Notes: MZ = monozygotic; DZ = dizygotic; OS = opposite-sex twins. aAmong those who had 
initiated.
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TABLE 2.    Standardized variance components and 95% conﬁ dence intervals between brackets from ﬁ tting two 
multivariate models to data on the initiation and progression of smoking and cannabis and other illicit drug use
 Smoking Cannabis use
Variable Initiation Progression Initiation Progression
Causal model
(-2 log likelihood = 9,963.550,
df = 10,601, AIC = -11,238.450)
 Additive genetic .58 .43 .32 –
  [.44, .72] [.32, .55] [.12, .53]
 Common environment .34 – .20 –
  [.21, .47]  [.02, .37]
 Unique environment .08 .10 .08 .17
  [.05, .12] [.05, .16] [.03, .14] [.07, .55]
 Initiation of smoking NA .41 .40 –
   [.24, .57] [.32, .48]
 Initiation of cannabis NA .06 NA .83a
   [.02, .13]  [.44, .93]
Cholesky factor model
(-2 log likelihood = 9,978.852,
df = 10,599, AIC = -11,219.148)
 Additive genetic .61 .13 .59 –
  [.53, .69] [.02, .24] [.51, .70]
 Common environment .31 .13 .30 –
  [.24, .37] [.02, .24] [.19, .40]
 Unique environment .08 .10 .11 .20
  [.06, .10] [.07, .14] [.08, .15] [.09, .33]
 Initiation of smoking NA .64 NA NA
   [.56, .67]
Initiation of cannabis NA NA NA .80b
     [.67, .89]
Correlations    
 Additive genetic .57 –
  [.44, .65]
 Common environment .82 –
  [.72, .95]
 Unique environment .99 –
  [.89, 1.00]
Notes: AIC = Akaike’s Information Criteria; NA = not applicable. aAlso includes path from initiation of smoking 
through initiation of cannabis/drug use (i.e., part of liability of cannabis/drug progression is attributable to the 
effect of liability to smoking initiation on cannabis/drug initiation); balso includes liabilities common to smoking 









.76 .58 .28 .57 .45 .28
.66 .32 .41
FIGURE 2.    Multivariate causal model of initiation and progression of smoking and initiation and progression of cannabis and other illicit drug use. IS = 
initiation of smoking, PS = progression of smoking; IC = initiation of cannabis use; PC = progression of cannabis use; AIS = additive genetic inﬂ uences on 
initiation of smoking; CIS = common/shared environmental inﬂ uences on initiation of smoking; EIS = unique/unshared environmental inﬂ uences on initiation 
of smoking; APS = additive genetic inﬂ uences on progression of smoking; EPS = unique environmental inﬂ uences on progression of smoking; AIC = additive 
genetic inﬂ uences on initiation of cannabis use; CIC = common environmental inﬂ uences on initiation of cannabis use; EIC = unique environmental inﬂ uences 
on initiation of cannabis use; EPC = unique environmental inﬂ uences on progression of cannabis use. Numbers reﬂ ect the respective path coefﬁ cients.
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Cholesky decomposition genetic factor model
 Results of the most parsimonious Cholesky decomposi-
tion, which hypothesizes that tobacco and cannabis use are 
correlated as a result of shared underlying liability, are shown 
in Figure 3. Pathways from initiation to progression for both 
smoking (path coefﬁ cient = .80) and use of cannabis/other 
illicit drugs (coefﬁ cient = .89) were strong, suggesting that 
the total variance of the progression stage was explained for 
a moderate to large part by inﬂ uences affecting the initiation 
stage.
 Based on the standardized estimates shown in Table 2, the 
model decomposes the total variation of smoking initiation 
into components of additive genetic factors (61%), common 
environmental factors (31%), and unique environmental 
factors (8%). The total variation in smoking progression is 
decomposed into additive genetic factors (13%), common 
environmental factors (13%), unique environmental factors 
(10%), plus variation due to smoking initiation (64%).
 The total variation in initiation of cannabis/other illicit 
drug use is decomposed into additive genetic factors (59%), 
common environmental factors (30%), and unique environ-
mental factors (11%). The total variation in cannabis/other 
illicit drug use progression is decomposed into unique envi-
ronmental factors (20%) and variation due to the direct effect 
of cannabis use initiation plus pathways common to initiation 
(80%).
 Finally, additive genetic correlation between initiation of 
smoking and cannabis use was .57, whereas the common 
environmental correlation was .82 and the unique environ-
mental correlation was .99 (Table 2).
Discussion
 In this study among Finnish adolescent twins, we tested 
whether a so-called causal model, in which latent constructs 
reﬂ ected the liability to initiate smoking directly affects such 
a latent construct for initiation of cannabis use, could explain 
the association between initiation and progression of tobacco 
and cannabis/other illicit drug use. We compared this model 
with a Cholesky model, reﬂ ecting correlation between ini-
tiation of smoking and cannabis use resulting from shared 
underlying liability (i.e., shared genetic and environmental 
inﬂ uences on use of these substances). We found some evi-
dence for the causal model, because our comparative model 
ﬁ tting showed that this model had a slightly better ﬁ t than the 
Cholesky model, in line with previous work of Neale et al. 
(2006). Especially in our younger population of adolescents, 
it appears that initiation of illicit drug use does not precede 
smoking initiation, whereas early-onset smoking is a strong 
predictor of illicit drug use by age 17.5 years (Korhonen 
et al., 2008). Thus, the results of the present study, com-
bined with our previous study, suggest that, in adolescence, 
smoking initiation may indeed have a direct impact on the 
propensity to initiate illicit drug use. Several mechanisms 
could be responsible for this strong association. For instance, 
Agrawal and Lynskey (2009) recently suggested, based on a 
longitudinal study of a large-scale U.S. adult sample, that the 
FIGURE 3.    Multivariate Cholesky model of initiation and progression of smoking and initiation and progression of cannabis and other illicit drug use. IS = 
initiation of smoking, PS = progression of smoking, IC = initiation of cannabis use; PC = progression of cannabis use; AIS = additive genetic inﬂ uences on 
initiation of smoking; CIS = common/shared environmental inﬂ uences on initiation of smoking; EIS = unique/unshared environmental inﬂ uences on initiation 
of smoking; APS = additive genetic inﬂ uences on progression of smoking; CPS = common environmental inﬂ uences on progression of smoking; EPS = unique 
environmental inﬂ uences on progression of smoking; AIC = additive genetic inﬂ uences on initiation of cannabis use; CIC = common environmental inﬂ uences 
on initiation of cannabis use; EIS = unique environmental inﬂ uences on initiation of cannabis use; EPC = unique environmental inﬂ uences on progression of 
cannabis use. Numbers reﬂ ect the respective path coefﬁ cients.
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shared inhalation route of administration may explain the as-
sociation often found between use of tobacco and cannabis. 
Shared environmental and social risk factors, including cul-
tural norms, may also account for this association (Ellickson 
et al., 2004; Golub et al., 2005; Wagner et al., 2005). Yet, 
more research is still needed to understand this particularly 
strong association.
 Because of the small difference in model fi t, our results 
are not conclusive. Nevertheless, although the Cholesky 
model also fi t the data adequately, we believe that the causal 
model better captures the complexity of the relationship be-
tween tobacco smoking and illicit drug use and may have a 
greater heuristic value. For instance, in the Cholesky model, 
once a person initiates the use of a specifi c substance, it can 
be related only to progression of use of that same substance. 
In contrast, our causal model showed associations across 
substances (i.e., an effect of tobacco initiation on illicit drug 
use initiation) and an effect of illicit drug use initiation on 
progression to daily smoking. This latter fi nding suggests 
that the propensity to initiate illicit drug use by age 17.5 
years may have some additional health-threatening risks 
refl ected by either more drug use or increased risk of daily 
smoking.
 Our causal model also indicates that the factors account-
ing for inter-individual variation in liability to illicit drug 
use initiation are largely the same for progression. This is 
refl ected by the moderate to large path coeffi cients between 
initiation of smoking and progression of smoking (.42) and 
between initiation of illicit drugs and progression of illicit 
drugs (.97) in Figure 2. This is consistent with results of a 
recent study (Shelton et al., 2007) showing a similarly high 
path coeffi cient between initiation of cannabis use and pro-
gression to using at least six times. Whether this may result 
in more regular illicit drug use has to be studied in the next 
follow-up of the present sample (ongoing in early adult-
hood), because at age 17.5 years, only 2.7% of all subjects 
had used illicit drugs 10 times or more.
 When we consider the genetic and environmental in-
fl uences on smoking and illicit drug use initiation and 
progression, it is striking to see that smoking initiation by 
late adolescence has a strong genetic component (58%). 
This fi nding is in line with several studies focusing on both 
adolescent and adult populations (Madden et al., 2004; Maes 
et al., 1999, 2006), although others have reported lower her-
itability for smoking onset in Dutch twins ages 12-25 years 
(Koopmans et al., 1999), in U.S. twins ages 17-18 years 
(Han et al., 1999), or in Finnish twins of the present cohort 
at ages 11-12 years (Rose et al., 2003). Similarly, we found 
a high heritability estimate for illicit drug use initiation and 
progression of use in our study. In a recent review, Agrawal 
and Lynskey (2006) concluded that, for cannabis use, a wide 
range of heritability estimates was found across studies, with 
18% as the lowest estimate in an adolescent twin sample 
(McGue et al., 2000) and 72% as the highest estimate in a 
female adolescent mixed sibling, twin, and adoption sample 
(Rhee et al., 2003). Our estimates of common environmental 
infl uences and nonshared environmental infl uences for ini-
tiation of mostly cannabis use are similar to those of most 
of the studies reviewed by Agrawal and Lynskey (2006). 
Interestingly, our fi nding that new common environmental 
factors did not explain the progression of cannabis/other 
illicit drug use, whereas unique environmental factors did, 
at least to some extent, is in line with several studies that 
focused on cannabis abuse in the adult twin sample (Ken-
dler and Prescott, 1998; Kendler et al., 2000; Tsuang et al., 
1998). Yet, we could not examine abuse because of the very 
low prevalence of more regular use in our relatively young 
sample. Our measure of progression of use was defi ned as 
using at least four times, and is therefore clearly different 
from the more serious forms of actual abuse or prolonged 
use of cannabis yet similar genetic and unique environmen-
tal infl uences may apply. This hypothesis needs to be tested 
further, and may point to shared genetic and (unique) envi-
ronmental infl uences on age-specifi c, risk-taking behavior 
regarding substance use in various age groups.
 Also of interest is the path coeffi cient of .32 from the 
propensity to initiate cannabis use to the progression of 
smoking. This path actually indicates that cannabis use may 
increase the risk of progressed smoking behavior. This fi nd-
ing is in line with the recent work of Patton et al. (2005) and 
Agrawal et al. (2008), although these studies focused on dif-
ferent phenotypes (i.e., frequent cannabis use as determinant 
or nicotine dependence as outcome, respectively).
 Several genetic and environmental infl uences present for 
smoking initiation also explain illicit drug use initiation. Ap-
proximately 40% of the genetic infl uence on cannabis/other 
illicit drug use initiation is shared with genetic infl uences 
on smoking initiation, which refl ects some shared genetic 
vulnerability. Nonetheless, specifi c genetic infl uences explain 
almost one third of illicit drug use initiation. Therefore, 
future studies may look for genotypes that are specifi cally 
related to this kind of substance use. Similarly, 17% of vari-
ance in progression of illicit drug use is explained by unique 
environmental factors, which may point to peer infl uences 
not shared by twins within twin pairs. Especially because 
there does not seem to be an infl uence of new common or 
shared environmental infl uences on both progression to daily 
smoking and progression of illicit drug use, it is worthwhile 
to examine discordance in environmental factors within twin 
pairs (e.g., nonshared friends or peers, or other effects) to 
gain more insight into which of these factors relates to more 
progressed substance use. Twin designs are especially useful 
for such analyses, because they can control within-family 
factors. We did not fi nd an overlap between unique environ-
mental factors that accounted for both smoking and illicit 
drug use. This could be because all overlap among those 
factors was explained by the overlapping variation between 
initiation of use of tobacco or illicit drugs.
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Strengths and limitations
 Although previous studies of Agrawal et al. (2004) and 
Lynskey et al. (2003) already tested the gateway theory 
for cannabis use in adult samples, our study is the fi rst to 
test and compare two alternative models on the theory of 
how tobacco use may affect cannabis use within one large 
adolescent twin sample. We applied a novel modeling tech-
nique—recently developed by Neale et al. (2006)—modifi ed 
that model for an adolescent population, and were able to fi t 
a causal model to the data. Fortunately, because of the rather 
narrow age range within our sample, there is little confound-
ing of age effects. Additionally, our 95% confi dence intervals 
of our estimated parameters were not too broad, which indi-
cates reasonable discrimination. However, when interpreting 
the results of this study, several potential limitations should 
be considered. The assessments of initiation and progression 
of smoking and illicit drug use were obtained by self-report, 
and our fi ndings are limited by the reliability of these data. 
Furthermore, smoking and use of illicit drugs were measured 
at a cross-sectional survey when the participants were, on 
average, age 17.5 years. A longitudinal design would have 
been more favorable and powerful to test our model. Un-
fortunately, the FinnTwin12 data included information on 
cannabis use only within the second follow-up survey at age 
17.5 years, but we were able to use interview data from a 
subsample of the twins at age 14 years to rule out cannabis 
use preceding smoking initiation at an early age. Also, we 
did not have data on age of cannabis/other illicit drug use 
onset. Generally speaking, our models provide approximate 
estimates of the relative contributions of genetic and envi-
ronmental factors to tobacco and illicit drug use. It must 
be noted that the genetic infl uences, estimated as A in our 
models, could also include gene–environment correlations. 
Finally, we could not differentiate progression of illicit drug 
use into several categories of severity (e.g., problematic use 
and abuse); therefore, our data did not permit advanced or 
other comprehensive multivariate modeling with multiple 
stages of illicit drug use. Future follow-up data of the pres-
ent sample is needed to adequately test whether a pathway 
from daily smoking to frequent cannabis/other illicit drug 
use exists.
Conclusions and implications
 By comparing two alternative models, our study provides 
further evidence that a causal model describes an association 
between smoking and later illicit drug use. However, it is 
diffi cult to discriminate between this causal model and the 
alternative model that describes an underlying common li-
ability for tobacco and illicit drug use. Therefore, advancing 
an understanding in this area will necessitate reports from 
multiple studies to evaluate convergence across datasets. Our 
fi ndings further suggest that several common genes may be 
related to tobacco use and illicit drugs but that a search for 
specifi c genes underlying illicit drug use is also justifi ed. 
Such specifi c genes may hold a key to understanding biologi-
cal vulnerabilities that lead to illicit drug use that could aid 
in the development of targeted interventions.
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